» Articles » PMID: 35218344

Association Between Low-density Lipoprotein Cholesterol and Cardiovascular Mortality in Statin Non-users: a Prospective Cohort Study in 14.9 Million Korean Adults

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2022 Feb 26
PMID 35218344
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Limited information is available on detailed sex/age-specific associations between low-density lipoprotein cholesterol (LDL-C) and cardiovascular disease (CVD) mortality and 'the optimal range' associated with the lowest CVD mortality in the general population.

Methods: Korean adults (N = 14 884 975) who received routine health screenings during 2009-2010 were followed until 2018 for CVD mortality.

Results: During 8.8 years (mean) of follow-up, 94 344 individuals died from CVD. LDL-C had U-curve associations with mortality from CVD and its subtypes, except haemorrhagic stroke. Optimal range was 90-149 mg/dL for CVD; 70-114 for ischaemic heart disease; 85-129 for ischaemic stroke; ≥85 for subarachnoid haemorrhage; ≥130 for intracerebral haemorrhage; 115-159 for hypertension and heart failure; and 100-144 for sudden cardiac death. Assuming linear associations between 100 and 300 mg/dL, LDL-C was positively associated with CVD mortality [hazard ratio (HR) per 39-mg/dL (1-mmol/L) higher LDL-C = 1.10], largely due to ischaemic heart disease (HR = 1.26), followed by sudden cardiac death (HR = 1.13), ischaemic stroke (HR = 1.11) and heart failure (HR = 1.05). Intracerebral haemorrhage (HR = 0.90), but not subarachnoid haemorrhage, had inverse associations. Women and older adults had weaker positive associations than men and younger adults (Pinteraction < 0.001 for both sex and age). Individuals aged 75-84 years had modest positive associations with CVD mortality, especially ischaemic heart disease and ischaemic stroke.

Conclusion: LDL-C had U-curve associations for CVD mortality. The associations and optimal ranges differed across CVD subtypes. Women and older adults had weaker positive associations than men and younger adults. Positive associations with ischaemic heart disease and ischaemic stroke were maintained in adults aged 75-84 years.

Citing Articles

Call for a consensual definition of dyslipidemia in coronary angiography trials.

Clerc A, Togni M, Cook S Front Cardiovasc Med. 2025; 12:1506149.

PMID: 39974594 PMC: 11836034. DOI: 10.3389/fcvm.2025.1506149.


Association of LDL-C with stroke and all-cause mortality in hypertensive patients with high risk of ASCVD.

Guo S, Wang C, Hu T, Lan L, Ge Z, Huang J Clin Hypertens. 2025; 31:e7.

PMID: 39944936 PMC: 11800280. DOI: 10.5646/ch.2025.31.e7.


Independent Association of Individual Lipid Abnormalities with Cardiovascular All-cause Mortality: A Prospective Cohort Study.

Zheng W, Zhang J, Huang Y, Wang S, Gao X, Yang Z High Blood Press Cardiovasc Prev. 2024; 32(1):107-119.

PMID: 39648198 PMC: 11782416. DOI: 10.1007/s40292-024-00694-6.


Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis.

Lee J, Jeon S, Lee H, Lee J Cardiovasc Diabetol. 2024; 23(1):364.

PMID: 39407266 PMC: 11481394. DOI: 10.1186/s12933-024-02457-y.


Different Associations between Lipid Levels and Risk for Heart Failure according to Diabetes Progression.

Lee S, Lee K, Youn J, Kim H, Han K, Kim M Diabetes Metab J. 2024; 49(1):105-116.

PMID: 39197833 PMC: 11788545. DOI: 10.4093/dmj.2024.0066.


References
1.
Stamler J, Wentworth D, Neaton J . Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986; 256(20):2823-8. View

2.
Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 316(19):1997-2007. DOI: 10.1001/jama.2016.15450. View

3.
Adabag A, Luepker R, Roger V, Gersh B . Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010; 7(4):216-25. PMC: 5014372. DOI: 10.1038/nrcardio.2010.3. View

4.
Yi S, Yi J, Ohrr H . Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults. Sci Rep. 2019; 9(1):1596. PMC: 6367420. DOI: 10.1038/s41598-018-38461-y. View

5.
Hawley C, Roefaro J, Forman D, Orkaby A . Statins for Primary Prevention in Those Aged 70 Years and Older: A Critical Review of Recent Cholesterol Guidelines. Drugs Aging. 2019; 36(8):687-699. PMC: 7245614. DOI: 10.1007/s40266-019-00673-w. View